Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Oncology Research and Treatment

Vol. 38, No. 11, 2015

Issue release date: November 2015

Add all to MyReading List
FREE ONLINE ACCESS
 
553

Editorial Board / Contents / Imprint / Guidelines for Authors

Oncol Res Treat 2015;38:553-558 (DOI:10.1159/000441747)
Free Access
Original Article
560

Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy

Gautschi O. · Stadelmann C. · Aebersold-Keller F. · König K. · Büttner R. · Heukamp L.C. · Betticher D. · Baumann C. · Buser K. · Calderoni A. · Casty A. · DʼAddario G. · Irlé C. · Mamot C. · Morant R. · Trojan A. · Pellicioli E. · Jehle-Schwertfeger S. · Aebi S. · Diebold J.
Oncol Res Treat 2015;38:560-569 (DOI:10.1159/000441367)
Free Access
570

Impact of p16 Alterations and Pretreatment Anemia on Toxicity in Head and Neck Cancer Patients Undergoing Definitive Radiochemotherapy

Becker-Schiebe M. · Sperling M. · Pinkert U. · Hoffmann W.
Oncol Res Treat 2015;38:570-576 (DOI:10.1159/000441344)
Free Access
577

Limited Prognostic Value of SUVmax Measured by F-18 FDG PET/CT in Newly Diagnosed Small Cell Lung Cancer Patients

Kim S.-J. · Chang S.
Oncol Res Treat 2015;38:577-585 (DOI:10.1159/000441289)
Free Access
586

Glycine Decarboxylase Expression Increased in p53-Mutated B Cell Lymphoma Mice

Li X. · Cui C. · Guo Y. · Yang G.
Oncol Res Treat 2015;38:586-589 (DOI:10.1159/000441595)
Free Access
590

Communication Preferences in Young, Middle-Aged, and Elderly Cancer Patients

Richter D. · Ernst J. · Lehmann C. · Koch U. · Mehnert A. · Friedrich M.
Oncol Res Treat 2015;38:590-595 (DOI:10.1159/000441312)
Free Access
Review Article
596

Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine

Vogel A. · Kullmann F. · Kunzmann V. · Al-Batran S.-E. · Oettle H. · Plentz R. · Siveke J. · Springfeld C. · Riess H.
Oncol Res Treat 2015;38:596-603 (DOI:10.1159/000441310)
Open Access Gateway
 
604

Congress Report

Oncol Res Treat 2015;38:604-605 (DOI:10.1159/000441748)
Free Access
606

Reports of Oncological Societies

Oncol Res Treat 2015;38:606-609 (DOI:10.1159/000441749)
Free Access
610

PharmaForum

Oncol Res Treat 2015;38:610-611 (DOI:10.1159/000441755)
Free Access
613

PharmaForum

Oncol Res Treat 2015;38:613 (DOI:10.1159/000441751)
Free Access
614

PharmaNews

Oncol Res Treat 2015;38:614-615 (DOI:10.1159/000441752)
Free Access
617

Meetings and Conferences

Oncol Res Treat 2015;38:617-618 (DOI:10.1159/000441754)
Free Access
Beilage
I

Status quo in der Zweitlinientherapie des NSCLC und Ausblick in die Zukunft

Oncol Res Treat 2015;38:I-VI (DOI:10.1159/000441935)
Free Access